Aberrantly activated phosphatidylinositol 3‐kinase (PI3K) pathway via amplification or mutation of PIK3CA, hyperactivation of RTKs, alteration of AKT or functional loss of PTEN occurs frequently in ESCC. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.